AstraZeneca PLC Chases Demon Disease Cure, Potential To Be A Blockbuster Drug

Published: Feb 17, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In 1785, the caricaturist Henry William Bunbury declared strong drink, aided by a demon, as the cause of the painful inflammatory disease known as gout. Two hundred years later, AstraZeneca Plc (AZN) may be on the verge of winning approval for a more effective treatment for the malady. Gout is having a resurgence, fueled by increasing rates of obesity and poor diet.

Help employers find you! Check out all the jobs and post your resume.

Back to news